Approvals/TGA/AMLODIPINE/VALSARTAN/HCT NOVARTIS 5/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

Approved

STANDARD

AMLODIPINE/VALSARTAN/HCT NOVARTIS 5/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

Approval Id: e31fdc7786ed19aa
Product Name: AMLODIPINE/VALSARTAN/HCT NOVARTIS 5/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
Artg Id: 158163
Artg Name: AMLODIPINE/VALSARTAN/HCT NOVARTIS 5/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2010-04-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-CMI-02743-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-03229-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e31fdc7786ed19aa

Type

Standard